Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page
- Check3 days agoChange DetectedThe page revision changed from v3.6.0 to v3.6.2. This indicates a minor update to the ClinicalTrials.gov entry, likely related to QC or editorial adjustments rather than changes to the study content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecruitment status on the study page was updated to indicate that no participants are being recruited, and several new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page version note was updated from v3.5.5 to v3.6.0, and the header label for interventions was standardized from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check25 days agoChange DetectedThe page shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a minor update to the page's revision history rather than a substantive change to the study details.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4. This signals a minor update to the study document metadata on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page, indicating a new version of the page template and related metadata. This change does not alter the study content or user-facing information.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.5.2. This appears to be a minor site update with no visible changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.